By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Third Rock Ventures 

29 Newbury Street
3rd Floor
Boston  Massachusetts  02116  U.S.A.
Phone: 617-585-2000 Fax: 617-859-2891



Company News
Third Rock Ventures Quietly Launches Tango Therapeutics in Editas Medicine (EDIT)’s HQ 3/7/2017 6:11:22 AM
Third Rock Ventures Release: Company Names Sarah Larson As Partner 1/26/2017 8:18:27 AM
Third Rock Ventures Names Industry Leader Michael W. Bonney As Partner 1/7/2016 12:01:00 PM
Third Rock Ventures and GlaxoSmithKline (GSK)’s SR One Launch Decibel Therapeutics With $52 Million, Expect to Hire 50-60 By Year End 10/15/2015 6:00:59 AM
Third Rock Ventures Leads Formation of Neon Therapeutics with $55 Million Series A Round 10/1/2015 6:04:02 AM
Ember Therapeutics and Third Rock Ventures — A Case Study in the Risks of Biotech Investments 9/10/2015 6:31:49 AM
Third Rock Ventures Sniffing Around Ex-Vertex (VRTX) Digs in Cambridge for Startups 5/18/2015 6:31:32 AM
Third Rock Ventures Co-Founder Mark Levin To Receive Massachusetts Biotechnology Council, Inc.’s Innovative Leadership Award 3/18/2015 12:06:19 PM
Third Rock Ventures Launches $45 Million Bay Area Startup Revolution Medicines to Squeeze More Drugs From Nature 2/4/2015 5:57:48 AM
SV Life Sciences And Third Rock Ventures Launch Transformative Medical Device Company Cibiem With $10 Million Series 9/26/2014 1:59:37 PM